In situ transitional cell carcinoma involvement of prostatic urethra: Bacillus calmette-guérin therapy without previous transurethral resection of the prostate

Joan Palou(Universitat Autònoma de Barcelona), J. Vicente(Universitat Autònoma de Barcelona), Pilar Laguna(Istanbul Medipol University), M. Montlleó(Universitat Autònoma de Barcelona), B. Xavier(Universitat Autònoma de Barcelona)
Urology
April 1, 1996
10.1016/s0090-4295(99)80481-6
Cited by 37

Related Papers

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
|European Urology|2008|617
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II
|European Urology|2008|252
Use of Haemostatic Agents and Glues during Laparoscopic Partial Nephrectomy: A Multi-Institutional Survey from the United States and Europe of 1347 Cases
|European Urology|2007|139
Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”
|European Urology|2020|132
A Review on Follow-Up Strategies for Renal Cell Carcinoma after Nephrectomy
|European Urology|2007|103